Short Interest in Prenetics Rises Sharply Short interest in Prenetics Global Limited increased by 22.1% in February, reaching 39,800 shares. This growth reflects heightened market activity around the company. Analysts maintained an “overweight” rating, with a target price of $9.00, as Prenetics continues to attract attention for its advancements in genomics-driven health sciences.2